World HIV drug treatment on target
Jeremy Laurance is a writer on health issues. He is former health editor of The Independent and the i and has covered the specialism for more than 20 years. He thinks the harm medicine does is under-appreciated, the harm it prevents over-rated, and that cycling works better than most drugs. He was named Specialist Journalist of the Year in the 2011 British Press Awards.
Thursday 19 July 2012
The world is more than half way to providing drug treatment for HIV to all those who need it, Aids experts said yesterday – but there may not be enough money to finish the job. In 2011, more than eight million people in developing countries were receiving antiretroviral therapy, a 20 per cent increase on the number in 2010.
The rate of growth is on track to achieve the target set in 2011 by the UN of 15 million HIV infected individuals receiving treatment by 2015, according to Michel Sidibé, executive director of UNAIDS, whose latest report is published today ahead of the 19th International Aids Conference in Washington next week.
Mr Sidibé said the world "deserves no less than a future of zero new HIV infections, zero discrimination and zero AIDS-related deaths". "The world is investing in this vision and the investment is paying off," he said.
But the international charity Médecins Sans Frontières (MSF) said progress was still too slow. Eric Goemaere, a senior MSF doctor, said: "Almost one in two people don't have access to the medicines they need to stay alive.
"If we are going to reach all the people who need treatment we are going to have to double the pace. Every day more people need to be put on treatment than the day before."
The UNAIDS report shows that while domestic funding for HIV has increased by 50 per cent since 2006, international donations have remained flat since 2008. Total resources have not increased, it said.
An extra 1.4 million people began receiving HIV treatment in 2011, but 2.5 million were newly infected, including 330,000 children. The total population living with HIV rose to 34.2 million, the highest level, reflecting the success of treatment in keeping people alive.
Two major threats lie ahead – the continuing shortage of funds caused by the global economic collapse – and the growth of drug resistance. The latter is currently low in most countries but rising in some – and the costs of combination treatments to combat it can be punitive – up to $6,000 a month.
In numbers: HIV and Aids
8m The number of people with HIV receiving antiretroviral treatment last year, up 20% since 2010 and half way to the UN's 15 million target by 2015.
2.5m The number of new HIV infections in 2011, down 20% in a decade.
24% The fall in child HIV infections in the two years from 2009 to 2011.
1.7m The number of people who died from Aids in 2011, down 24% from its peak in 2005.
2 Infection rates in women aged 15-24 are twice as high as men in the same bracket.
34.2m The number of people living with HIV in 2011 – the highest number since records began.
Life & Style blogs
Google Maps Pacman: company offers chance to play arcade classic on streets around the world
Google April Fools': company unveils backwards search engine and huggable digital assistant
Gamers confess the worst things they've done in The Sims
The Clove Club: The restaurant where you will pre-pay for your food
Facebook virtual reality optical illusion less impressive than originally thought
- 1 Katie Hopkins attacked me on Twitter — so I reported her to the police for inciting racial hatred
- 2 I might be an MP, but that doesn't stop me fighting sexism with my breasts
- 3 Google April Fools': company unveils backwards search engine and huggable digital assistant
- 4 April Fools' Day 2015: The best hoax news stories from around the internet
- 5 Gamers confess the worst things they've done in The Sims
£18000 - £22000 per annum: Recruitment Genius: This is an exciting opportunity...
£30000 - £35000 per annum: Recruitment Genius: Working closely with the market...
£20000 - £50000 per annum: Recruitment Genius: A reputable company, famed for ...
Negotiable: Ashdown Group: The Ashdown Group has been engaged by a highly resp...